Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

High density lipoproteins and atherosclerosis: emerging aspects.

Sala F, Catapano AL, Norata GD.

J Geriatr Cardiol. 2012 Dec;9(4):401-7. doi: 10.3724/SP.J.1263.2011.12282.

2.

HDLs, immunity, and atherosclerosis.

Norata GD, Pirillo A, Catapano AL.

Curr Opin Lipidol. 2011 Oct;22(5):410-6. doi: 10.1097/MOL.0b013e32834adac3. Review.

PMID:
21881500
3.

Emerging role of high density lipoproteins as a player in the immune system.

Norata GD, Pirillo A, Ammirati E, Catapano AL.

Atherosclerosis. 2012 Jan;220(1):11-21. doi: 10.1016/j.atherosclerosis.2011.06.045. Epub 2011 Jul 2. Review.

PMID:
21783193
4.

High-density lipoproteins from probucol-treated patients have increased capacity to promote cholesterol efflux from mouse peritoneal macrophages loaded with acetylated low-density lipoproteins.

Ishigami M, Yamashita S, Sakai N, Hirano K, Arai T, Maruyama T, Takami S, Koyama M, Kameda-Takemura K, Matsuzawa Y.

Eur J Clin Invest. 1997 Apr;27(4):285-92.

PMID:
9134376
5.

High-density lipoprotein: key molecule in cholesterol efflux and the prevention of atherosclerosis.

Meurs I, Van Eck M, Van Berkel TJ.

Curr Pharm Des. 2010 May;16(13):1445-67. Review.

PMID:
20199377
6.

Inflammatory reactions in the pathogenesis of atherosclerosis.

Fan J, Watanabe T.

J Atheroscler Thromb. 2003;10(2):63-71. Review.

7.
8.

Lipoproteins and atherosclerosis.

Babiak J, Rudel LL.

Baillieres Clin Endocrinol Metab. 1987 Aug;1(3):515-50. Review.

PMID:
3330421
10.
11.

Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis.

Wolfrum C, Poy MN, Stoffel M.

Nat Med. 2005 Apr;11(4):418-22. Epub 2005 Mar 27.

PMID:
15793583
12.
13.

Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.

Patel S, Drew BG, Nakhla S, Duffy SJ, Murphy AJ, Barter PJ, Rye KA, Chin-Dusting J, Hoang A, Sviridov D, Celermajer DS, Kingwell BA.

J Am Coll Cardiol. 2009 Mar 17;53(11):962-71. doi: 10.1016/j.jacc.2008.12.008.

14.

Apolipoprotein M likely extends its anti-atherogenesis via anti-inflammation.

Huang XS, Zhao SP, Hu M, Luo YP.

Med Hypotheses. 2007;69(1):136-40. Epub 2007 Jan 10.

PMID:
17218068
15.

Dual role of lipoproteins in endothelial cell dysfunction in atherosclerosis.

Stancu CS, Toma L, Sima AV.

Cell Tissue Res. 2012 Aug;349(2):433-46. doi: 10.1007/s00441-012-1437-1. Epub 2012 May 18. Review.

PMID:
22592627
16.

HDL2 of heavy alcohol drinkers enhances cholesterol efflux from raw macrophages via phospholipid-rich HDL 2b particles.

Mäkelä SM, Jauhiainen M, Ala-Korpela M, Metso J, Lehto TM, Savolainen MJ, Hannuksela ML.

Alcohol Clin Exp Res. 2008 Jun;32(6):991-1000. doi: 10.1111/j.1530-0277.2008.00660.x.

PMID:
18498551
17.

Dual effect of hypochlorite in the modification of high density lipoproteins.

Pirillo A, Uboldi P, Catapano AL.

Biochem Biophys Res Commun. 2010 Dec 17;403(3-4):447-51. doi: 10.1016/j.bbrc.2010.11.053. Epub 2010 Nov 19.

PMID:
21094143
18.

Lipoproteins, macrophage function, and atherosclerosis: beyond the foam cell?

Rader DJ, Puré E.

Cell Metab. 2005 Apr;1(4):223-30. Review.

19.

Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice.

Föger B, Chase M, Amar MJ, Vaisman BL, Shamburek RD, Paigen B, Fruchart-Najib J, Paiz JA, Koch CA, Hoyt RF, Brewer HB Jr, Santamarina-Fojo S.

J Biol Chem. 1999 Dec 24;274(52):36912-20.

20.

Cholesterol efflux by acute-phase high density lipoprotein: role of lecithin: cholesterol acyltransferase.

Khovidhunkit W, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C.

J Lipid Res. 2001 Jun;42(6):967-75.

Supplemental Content

Support Center